Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Reports Preliminary Q4 Revenues of $355M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker said Thursday after the close of the market that it expects to report total revenue for the fourth quarter of more than $355 million.

The updated preliminary results follow its Jan. 13 announcement, when the company had said that revenues for the quarter would be greater than $340 million. GAAP operating margin for Bruker Scientfic Instruments is now projected to exceed 18 percent, the company added. However, it did not provide a revenue figure.

Revenue for Bruker Energy & Supercon Technologies is anticipated to exceed $20 million, a 75 percent improvement over Q4 2008 results. Operating loss for the division is expected to shrink, the company said without elaborating.

Bruker is scheduled to release its fourth-quarter and full-year 2009 results on Feb. 25.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.